二黄祛脂颗粒联合水飞蓟宾胶囊对非酒精性脂肪肝患者脂肪肝指数、炎症因子及自噬相关基因水平的影响  

Effects of Erhuang Quzhi Granules Combined with Silibinin Capsules on Fatty Liver Index,Inflammatory Factors and Autophagy-Related Gene Levels in Patients with Nonalcoholic Fatty Liver Disease

作　　者：陈平[1] 龚晓清 李晓红 尹春燕 滕佳欢 CHEN Ping;GONG Xiao-Qing;LI Xiao-Hong;YIN Chun-Yan;TENG Jia-Huan(Zigong First People's Hospital,Zigong 643020 Sichuan,China)

机构地区：[1]自贡市第一人民医院,四川自贡643020

出　　处：《广州中医药大学学报》2024年第6期1422-1429,共8页Journal of Guangzhou University of Traditional Chinese Medicine

基　　金：国家自然科学基金资助项目(编号:81802062)。

摘　　要：【目的】探讨二黄祛脂颗粒联合水飞蓟宾胶囊对非酒精性脂肪肝(NAFLD)患者脂肪肝指数、炎症因子及自噬相关基因水平的影响。【方法】将126例痰瘀互结型NAFLD患者随机分为对照组和观察组,每组各63例。对照组给予水飞蓟宾胶囊口服治疗,观察组在对照组的基础上给予二黄祛脂颗粒口服治疗,疗程为3个月。观察2组患者治疗前后脂肪肝指数、炎症因子[白细胞介素6(IL-6)、肿瘤坏死因子α(TNF-α)]、肝功能及血脂指标[丙氨酸氨基转移酶(ALT)、天冬氨酸氨基转移酶(AST)、γ谷氨酰转肽酶(GGT)、总胆固醇(TC)、甘油三酯(TG)、高密度脂蛋白胆固醇(HDL-C)、低密度脂蛋白胆固醇(LDL-C)]、自噬相关基因[自噬相关基因7(ATG7)、肌球蛋白样BCL2结合蛋白(Beclin 1)]水平的变化情况,并评价2组患者的临床疗效和安全性。【结果】(1)疗效方面,治疗3个月后,观察组的总有效率为90.48%(57/63),对照组为71.43%(45/63),组间比较(χ^(2)检验),观察组的疗效明显优于对照组(P<0.01)。(2)脂肪肝指数方面,治疗后,2组患者的脂肪肝指数均较治疗前明显降低(P<0.05),且观察组对脂肪肝指数的降低幅度明显优于对照组(P<0.01)。(3)炎症因子方面,治疗后,2组患者血清IL-6、TNF-α水平均较治疗前明显降低(P<0.05),且观察组对血清IL-6、TNF-α水平的降低幅度均明显优于对照组(P<0.05)。(4)肝功能方面,治疗后,2组患者血清ALT、AST、GGT水平均较治疗前明显降低(P<0.05),且观察组对血清ALT、AST、GGT水平的降低幅度均明显优于对照组(P<0.05)。(5)血脂方面,治疗后,2组患者血清TG、TC、LDL-C水平均较治疗前明显降低(P<0.05),血清HDL-C水平均较治疗前明显升高(P<0.05),且观察组对血清TG、TC、LDL-C水平的降低幅度及对血清HDL-C水平的升高幅度均明显优于对照组(P<0.05)。(6)自噬相关基因方面,治疗后,2组患者的血清ATG7、Beclin 1水平均较治疗前明显升高(Objective To investigate the effects of Erhuang Quzhi Granules combined with Silibinin Capsules on fatty liver index,inflammatory factors and autophagy-related gene levels in patients with nonalcoholic fatty liver disease(NAFLD).Methods A total of 126 patients with NAFLD of phlegm blended with blood stasis type were randomly divided into control group and observation group,with 63 cases in each group.The control group was treated with oral use of Silibinin Capsules,and the observation group was treated with oral use of Erhuang Quzhi Granules on the basis of treatment for the control group.The course of treatment lasted for 3 months.Before and after treatment,the two groups were observed in the changes of fatty liver index,and the levels of inflammatory factors of interleukin 6(IL-6)and tumor necrosis factor alpha(TNF-α),liver function and blood lipid indicators of alanine aminotransferase(ALT),aspartate aminotransferase(AST),-glutamyl transpeptidase(GGT),total cholesterol(TC),triglyceride(TG),high-density lipoprotein cholesterol(HDL-C)and low-density lipoprotein cholesterol(LDL-C),and autophagy-related genes of autophagy-related gene 7(ATG7)and myosin-like BCL2 binding protein(Beclin 1).After treatment,the clinical efficacy and safety of the two groups were evaluated.Results(1)After 3 months of treatment,the total effective rate of the observation group was 90.48%(57/63),and that of the control group was 71.43%(45/63).The intergroup comparison(tested by chi-square test)showed that the efficacy of the observation group was significantly superior to that of the control group(P<0.01).(2)After treatment,the fatty liver index of the two groups was significantly decreased compared with that before treatment(P<0.05),and the decrease of fatty liver index in the observation group was significantly superior to that in the control group(P<0.01).(3)After treatment,the serum levels of inflammatory factors of IL-6 and TNF-αin the two groups were significantly lower than those before treatment(P<0.05),and the decrease of seru

关 键 词：二黄祛脂颗粒 水飞蓟宾胶囊 非酒精性脂肪肝(NAFLD) 痰瘀互结型 脂肪肝指数 炎症因子 自噬相关基因 

分 类 号：R259.755[医药卫生—中西医结合]